Atlas Trials

An Open-labelled Clinical Trial of Live Attenuated Varicella Vaccines to Evaluate the Immunity Persistence After Primary Immunization and Safety and Immunogenicity After the Booster Immunization

Clinical trial NCT05150392 · COMPLETED

Trial details

NCT number
NCT05150392
Sponsor
Sinovac (Dalian) Vaccine Technology Co., Ltd.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Varicella
Start date
2018-07-11
Primary completion
2018-08-11
Enrollment
1193

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.